Pomerantz Law Firm Launches Investigation into Neogen Corporation for Possible Securities Fraud

Investor Alert: Pomerantz Law Firm Investigates Neogen Corporation

Overview

Pomerantz LLP, a leading firm in class action litigation, is currently investigating allegations on behalf of investors in Neogen Corporation (NASDAQ: NEOG). This investigation looks into potential securities fraud and identifies whether any unlawful business practices were engaged by Neogen and its executives.

Background on Neogen Corporation

Neogen Corporation is a well-known provider of food and animal safety solutions. However, its reputation has been called into question following serious issues with one of its veterinary products. On September 29, 2026, the U.S. Food and Drug Administration (FDA) announced it had issued a warning letter to Neogen regarding its veterinary wound care product, Neogen Vet HYCOAT (a solution of hyaluronate sodium). The investigation linked this product to severe infections and the deaths of at least 20 horses. This incident marks one of the largest quality defect-related deaths connected to an FDA-regulated veterinary medical product.

Implications for Investors

This alarming news has had tangible repercussions for Neogen’s stock performance. Following the FDA’s announcement, Neogen's share price plummeted by $0.99, or approximately 7.22%, closing at $12.73 per share. Investors affected by the incident are urged to contact Pomerantz LLP as they explore potential legal actions.

The Role of Pomerantz LLP

Pomerantz LLP is recognized as one of the foremost law firms specializing in corporate, securities, and antitrust class action litigation. With decades of experience and a legacy of fighting for the rights of victims affected by securities fraud, Pomerantz has recovered substantial damages for its clients in the past. Its involvement in Neogen’s case underscores the seriousness of the situation and the firm's commitment to holding corporations accountable for their actions.

Steps Moving Forward

Investors holding stock in Neogen Corporation are advised to reach out to Danielle Peyton at Pomerantz LLP via the provided contact details. The firm is currently urging all affected investors to consider joining a class action lawsuit. Legal steps are crucial in the wake of such incidents, especially as more details emerge regarding Neogen’s possible liabilities.

Final Thoughts

The investigation by Pomerantz LLP serves as a critical alert for investors in Neogen Corporation, highlighting the importance of due diligence in the investments made in the life sciences sector. As the case unfolds, it remains to be seen how Neogen will respond and what implications may arise for both the company and its shareholders in the coming months.

For further inquiries or to join the ongoing investigation, investors are encouraged to contact Pomerantz LLP directly. The firm’s expertise in securities litigation puts it in a strong position to navigate the complexities of this evolving situation.

For updates on this investigation and other related legal news, stay tuned to this channel.